PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 1869638

Tumor necrosis factor.

P E Wakefield·W D James·C P Samlaska·M S Meltzer
View original source ↗Export metadata ↓

Abstract

Tumor necrosis factor is important in systemic and cutaneous defense, homeostasis, and many disease states. The numerous and diverse effects of tumor necrosis factor are best understood when considered as concentration-dependent, with normal homeostasis progressing to defense followed by toxic effects. Understanding tumor necrosis factor is important for the dermatologist as more studies appear in our literature and potential clinical uses of tumor necrosis factor (and possible anti-tumor necrosis factor agents) are realized.

Explore related subjects

Communicable DiseasesHumansRecombinant ProteinsSkinSkin DiseasesSkin NeoplasmsSkin Physiological PhenomenaTumor Necrosis Factor-alphaJournal ArticleResearch Support, Non-U.S. Gov'tReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P E Wakefield, W D James, C P Samlaska, M S Meltzer. 1991. Tumor necrosis factor.. https://doi.org/10.1016/0190-9622(91)70102-8

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Application of the promotion time cure model with time-changing exposure to the study of HIV/AIDS and other infectious diseases.

Infectious diseases are caused by single or successive contacts with pathogens. Nevertheless, contacts with pathogens do not implicate infection. In 1993, Yakovlev et al. proposed a model to study a population of cancer patients with a cured fraction, a well adapted model to describe an infectious disease with a unique infection occasion. Extensions of this model have been proposed in the recent years. We present a mechanistic formulation in the context of infectious diseases with multiple infection occasions. It is a mixture model that enables to study risk factors associated with infection intensity at each infection occasion and factors shortening the delay from exposure to clinical event. Simulations are performed to evaluate the model fitting and two examples are presented for illustration: an analysis of an HIV-1 mother-to-child transmission data set and an analysis of nosocomial urinary tract infections data set.

Communicable Diseases↗
PubMed2007

On observing and analyzing disease versus signals.

The immune system has co-evolved with microbes that cause acute infectious disease. Immune responses must be appropriate to allow survival of both the individual and the species. These responses involve complex interactions that often go unmeasured.

Communicable Diseases↗